本页面由Tiger Trade Technology Pte. Ltd.提供服务

Arcturus Therapeutics Ltd.

12.61
-1.1300-8.22%
盘后:12.860.2500+1.98%19:56 EDT
成交量:41.99万
成交额:541.88万
市值:3.58亿
市盈率:-3.79
高:13.75
开:13.64
低:12.57
收:13.74
52周最高:24.17
52周最低:5.50
股本:2,841.25万
流通股本:2,627.53万
量比:0.52
换手率:1.60%
股息:- -
股息率:- -
每股收益(TTM):-3.3289
每股收益(LYR):-2.4021
净资产收益率:-46.31%
总资产收益率:-23.96%
市净率:2.09
市盈率(LYR):-5.25

数据加载中...

2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/05

重要事件披露

Form 8-K - Current report
2024/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/19

重要事件披露

Form 8-K - Current report
2024/03/14

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/27

重要事件披露

Form 8-K - Current report
2023/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities